Why the study?
The role and mechanisms by which artesunate affects platelet aggregation and thrombus formation were not understood.
Does artesunate inhibit collagen-induced platelet activation and thrombus formation in human platelets?
Does artesunate inhibit collagen-induced platelet activation and thrombus formation in human platelets?
Artesunate inhibits collagen-induced human platelet activation and thrombus formation by regulating cyclic nucleotides and intracellular calcium, suggesting potential as a novel antiplatelet agent.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for artesunate in antithrombotic therapy; prospective trials needed before clinical consideration.
Discovery of new substance that can regulate platelet aggregation or suppress aggregation will aid in the prevention and treatment of cardiovascular diseases.Artesunate is a compound from plant roots of Artemisia or Scopolia, and its effects have shown to be promising in areas of anticancer and Alzheimer's disease.However, the role and mechanisms by which artesunate affects the aggregation of platelets, and the formation of a thrombus are currently not understood.This study examined the ways artesunate affects platelets activation and thrombus formation induced by collagen.As a result, cAMP and cGMP production were increased significantly by artesunate relative to the doses, as well as phosphorylated VASP and IP 3 R, substrates to cAMP-dependent kinase and cGMP-dependent kinase, in a significant manner.The Ca 2+ normally mobilized from the dense tubular system was inhibited due to IP 3 R, phosphorylation from artesunate, and phosphorylated VASP aided in inhibiting platelet activity via αIIb/β 3 platelet membrane inactivation and inhibiting fibrinogen binding.Finally, artesunate inhibited thrombin-induced thrombus formation.Therefore, we suggest that artesunate has importance with cardiovascular diseases stemming from the abnormal platelets activation and thrombus formation by acting as an effective prophylactic and therapeutic agent.
No takes yet. Share an insight, caveat, or question.
Dong‐Ha Lee (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: